Innovid Corp.
NYSE:CTV
3.1 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Revenue
| 139.882 | 127.117 | 90.291 | 68.801 | 56.338 |
| Cost of Revenue
| 33.805 | 30.187 | 17.785 | 12.365 | 10.583 |
| Gross Profit
| 106.077 | 96.93 | 72.506 | 56.436 | 45.755 |
| Gross Profit Ratio
| 0.758 | 0.763 | 0.803 | 0.82 | 0.812 |
| Reseach & Development Expenses
| 26.878 | 31.118 | 24.619 | 18.283 | 14.766 |
| General & Administrative Expenses
| 39.086 | 39.144 | 20.68 | 8.221 | 7.625 |
| Selling & Marketing Expenses
| 45.571 | 50.266 | 33.056 | 28.81 | 29.409 |
| SG&A
| 84.657 | 89.41 | 53.736 | 37.031 | 37.034 |
| Other Expenses
| 0 | 6.143 | 0 | 0 | 0 |
| Operating Expenses
| 111.535 | 126.671 | 78.355 | 55.314 | 51.8 |
| Operating Income
| -16.154 | -29.741 | -5.849 | 1.122 | -6.045 |
| Operating Income Ratio
| -0.115 | -0.234 | -0.065 | 0.016 | -0.107 |
| Total Other Income Expenses Net
| -13.383 | 13.348 | -4.386 | -0.734 | -0.387 |
| Income Before Tax
| -29.537 | -16.393 | -10.235 | 0.388 | -6.432 |
| Income Before Tax Ratio
| -0.211 | -0.129 | -0.113 | 0.006 | -0.114 |
| Income Tax Expense
| 2.374 | 2.017 | 1.237 | 1.2 | 0.902 |
| Net Income
| -31.911 | -18.41 | -11.472 | -0.812 | -7.334 |
| Net Income Ratio
| -0.228 | -0.145 | -0.127 | -0.012 | -0.13 |
| EPS
| -0.23 | -0.14 | -0.43 | -0.051 | -0.062 |
| EPS Diluted
| -0.23 | -0.14 | -0.43 | -0.051 | -0.062 |
| EBITDA
| -5.458 | -23.598 | -5.188 | 1.852 | -5.614 |
| EBITDA Ratio
| -0.039 | -0.186 | -0.057 | 0.027 | -0.1 |